Detalhe da pesquisa
1.
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Circulation
; 147(4): 284-295, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335517
2.
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.
Diabetes Obes Metab
; 25(9): 2765-2769, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246798
3.
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.
J Psychoactive Drugs
; : 1-17, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615379